Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-02 | BIOGEN INC. | Singhal Priya
(Head of Development) |
S | Common Stock | D | 93 | $213.09 - $213.09 | $19,817 |
2024-04-01 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
M | Common Stock | A | 240 | $0.00 - $0.00 | $0 |
2024-04-01 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
F | Common Stock | D | 117 | $214.83 - $214.83 | $25,135 |
2024-02-22 | BIOGEN INC. | Singhal Priya
(Head of Development) |
S | Common Stock | D | 262 | $221.23 - $221.23 | $57,962 |
2024-02-16 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
M | Common Stock | A | 5037 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
F | Common Stock | D | 2437 | $219.08 - $219.08 | $533,897 |
2024-02-16 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
M | Common Stock | A | 4704 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
F | Common Stock | D | 2264 | $219.08 - $219.08 | $495,996 |
2024-02-16 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
M | Common Stock | A | 2017 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
F | Common Stock | D | 952 | $219.08 - $219.08 | $208,564 |
2024-02-16 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
M | Common Stock | A | 1345 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
F | Common Stock | D | 396 | $219.08 - $219.08 | $86,755 |
2024-02-16 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
M | Common Stock | A | 6720 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
F | Common Stock | D | 3438 | $219.08 - $219.08 | $753,196 |
2024-02-16 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
M | Common Stock | A | 1260 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
F | Common Stock | D | 610 | $219.08 - $219.08 | $133,638 |
2024-02-16 | BIOGEN INC. | Singhal Priya
(Head of Development) |
S | Common Stock | D | 108 | $221.49 - $221.49 | $23,920 |
2024-02-16 | BIOGEN INC. | Singhal Priya
(Head of Development) |
M | Common Stock | A | 1208 | $0.00 - $0.00 | $0 |
2024-02-16 | BIOGEN INC. | Singhal Priya
(Head of Development) |
F | Common Stock | D | 468 | $219.08 - $219.08 | $102,528 |
2024-02-15 | BIOGEN INC. | Rowinsky Eric K
(Director) |
P | Common Stock | A | 455 | $222.54 - $222.54 | $101,255 |
2024-02-09 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
M | Common Stock | A | 2158 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
F | Common Stock | D | 634 | $240.98 - $240.98 | $152,781 |
2024-02-12 | BIOGEN INC. | Singhal Priya
(Head of Development) |
S | Common Stock | D | 419 | $239.45 - $239.45 | $100,329 |
2024-02-09 | BIOGEN INC. | Singhal Priya
(Head of Development) |
M | Common Stock | A | 1212 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | Singhal Priya
(Head of Development) |
F | Common Stock | D | 374 | $240.98 - $240.98 | $90,126 |
2024-02-09 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
M | Common Stock | A | 2272 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
F | Common Stock | D | 761 | $240.98 - $240.98 | $183,385 |
2024-02-09 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
M | Common Stock | A | 3257 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
F | Common Stock | D | 1431 | $240.98 - $240.98 | $344,842 |
2024-02-09 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
M | Common Stock | A | 833 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
F | Common Stock | D | 245 | $240.98 - $240.98 | $59,040 |
2024-02-09 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
M | Common Stock | A | 1515 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
F | Common Stock | D | 445 | $240.98 - $240.98 | $107,236 |
2024-02-09 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
M | Common Stock | A | 2575 | $0.00 - $0.00 | $0 |
2024-02-09 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
F | Common Stock | D | 938 | $240.98 - $240.98 | $226,039 |
2024-02-08 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
M | Common Stock | A | 2190 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | ALEXANDER SUSAN H
(EVP Chief Legal Officer) |
F | Common Stock | D | 655 | $240.30 - $240.30 | $157,396 |
2024-02-08 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
M | Common Stock | A | 1635 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | Gregory Ginger
(EVP, Human Resources) |
F | Common Stock | D | 498 | $240.30 - $240.30 | $119,669 |
2024-02-08 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
M | Common Stock | A | 2043 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | Izzar Rachid
(Head of Global Product Strat.) |
F | Common Stock | D | 621 | $240.30 - $240.30 | $149,226 |
2024-02-08 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
M | Common Stock | A | 788 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | Kramer Robin
(Chief Accounting Officer) |
F | Common Stock | D | 253 | $240.30 - $240.30 | $60,795 |
2024-02-08 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
M | Common Stock | A | 2335 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | MCDONNELL MICHAEL R
(EVP, Chief Financial Officer) |
F | Common Stock | D | 765 | $240.30 - $240.30 | $183,829 |
2024-02-08 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
M | Common Stock | A | 2101 | $0.00 - $0.00 | $0 |
2024-02-08 | BIOGEN INC. | Murphy Nicole
(Head of Pharm Ops and Tech) |
F | Common Stock | D | 638 | $240.30 - $240.30 | $153,311 |
2024-02-02 | BIOGEN INC. | Singhal Priya
(Head of Development) |
S | Common Stock | D | 634 | $245.93 - $245.93 | $155,919 |
2024-02-01 | BIOGEN INC. | Singhal Priya
(Head of Development) |
M | Common Stock | A | 1828 | $0.00 - $0.00 | $0 |
2024-02-01 | BIOGEN INC. | Singhal Priya
(Head of Development) |
F | Common Stock | D | 561 | $247.83 - $247.83 | $139,032 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |